NCT00482066 - Abatacept in ANCA Associated Vasculitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

ANCA-associated Vasculitis

Interventions

DRUG

Abatacept (Orencia)

"500mg for patients under 60kg 750mg for patients 60-100kg~1g for patients\>100kg given as i.v. infusion over 30 minutes at day 0, 14, 28 and then monthly for a further 11 months 914 infusions in total) placebo groups receive saline only I.v."

Trial Locations (1)

W12 0NN

Imperial College London, Hammersmith Hospital, London